A 63-year-old female and a 63-year-old male with resolved HBV infection suffered a relapse of malignant lymphoma. After bendamustine hydrochloride monotherapy, HBV reactivation occurred. Entecavir treatment was commenced immediately, with tests for HBV DNA negative without development of hepatitis. Regular monitoring of HBV DNA based on the guidelines from the Japan Society of Hepatology was useful.
|Number of pages||6|
|Journal||Journal of Japanese Society of Gastroenterology|
|Publication status||Published - Sep 2016|
All Science Journal Classification (ASJC) codes